Abstract:Background: Silk fibroin is the main protein of silk, and it has recently been evaluated for drug delivery applications due to its excellent properties. Specifically, silk fibroin exhibits good biocompatibility, biodegradability and low immunogenicity. Fibroin nanoparticles have attracted attention due to their high binding ability to different drugs as well as their ability for controlled drug release. The improvement of the therapeutic efficiency of drug encapsulation is important and depends on the particle size, the chemical structure and the properties of the silk fibroin nanoparticles. Methods: There is a variety of methods for the preparation of fibroin nanoparticles such as (i) electrospraying and desolvation method, (ii) supercritical fluid technologies, (iii) capillary-microdot technique, (iv) salting out etc. Furthermore, various techniques have been used for the characterization of nanoparticles such as SEM (scanning electron microscopy), TEM (transmission electron microscopy), DLS (dynamic light scattering), Zeta-potential and FTIR (Fourier transform infrared spectroscopy). Different drugs (paclitaxel, curcumin, 5-fluorouracil etc) have been encapsulated in fibroin nanoparticles. Results: Each separated synthesis method has different advantages such as (i) high yield, (ii) avoid use of toxic solvents, (iii) low cost, (iv) controllable particle size, (v) no organic solvent residue, (vi) simplicity of operation, (vii) small particles size, (viii) homeliness of operation, (ix) restrainable particle size, (x) easy and safe to operate, (xi) no use of organic solvent. Moreover, some major drugs studied are Floxuridine, Fluorouracil, Curcumin, Doxorubicin, Metotrexate, Paclitaxel and Doxorubicin, Horseradish peroxidase. All the above combinations (preparation method-drug) are studied in detail. Conclusion: Various drugs have been encapsulated successfully in silk fibroin and all of them exhibit a significant release rate. Finally, the encapsulation efficiency and release rate depend on the molecular weight of the drugs and it can be adjusted by controlling the crystallinity and concentration of silk fibroin.

Colloidal Stability of Silk Fibroin Nanoparticles Coated with Cationic Polymer for Effective Drug Delivery

Self-stabilized Silk Sericin-Based Nanoparticles: in Vivo Biocompatibility and Reduced Doxorubicin-Induced Toxicity

In Situ Protein-Templated Porous Protein-Hydroxylapatite Nanocomposite Microspheres for Ph-Dependent Sustained Anticancer Drug Release

Silk Fibroin-Based Nanoparticles for Drug Delivery

Fabrication of silk fibroin nanoparticles for controlled drug delivery

Silk Fibroin as a Functional Biomaterial for Drug and Gene Delivery

The Systematic Evaluation of Physicochemical and Biological Properties In Vitro and In Vivo for Natural Silk Fibroin Nanoparticles

A Review for the Synthesis of Silk Fibroin Nanoparticles with Different Techniques and Their Ability to be Used for Drug Delivery

Silk Fibroin Nanoparticles (SFNs) for nanoencapsulation of bioactive molecules

Preparation and Characterization of Cellulose/Silk Fibroin Composite Microparticles for Drug-Controlled Release Applications

Silk Fibroin Based Drug Delivery Applications: Promises and Challenges

Cellulose-Silk Fibroin Composite Particles for Hydrophilic Drug-Controlled Release System: Preparation and Characterization

Silk fibroin as an organic polymer for controlled drug delivery

Self-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinoma

Stability and cytocompatibility of silk fibroin-capped gold nanoparticles

Natural Non-Mulberry Silk Nanoparticles for Potential-Controlled Drug Release

Silk fibroin as a vehicle for drug delivery applications

Biomimetic Nucleation of Metal–Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core–Shell-Structured pH-Responsive Anticancer Drug Carriers

Fabricated porous silk fibroin particles for pH-responsive drug delivery and targeting of tumor cells

Silk fibroin nanomaterials